Burakoff Steven 4
4 · GENZYME CORP · Filed Apr 6, 2011
Insider Transaction Report
Form 4
GENZYME CORPGENZ
Burakoff Steven
Director
Transactions
- Exercise/Conversion
Genzyme common stock (GENZ)
2011-04-04+2,375→ 2,375 total - Disposition to Issuer
Genzyme common stock (GENZ)
2011-04-04$74.00/sh−2,375$175,750→ 0 total - Exercise/Conversion
Restricted Stock Units
2011-04-04−2,375→ 0 totalExercise: $0.00→ Genzyme common stock (GENZ) (2,375 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-04-04$51.52/sh−7,125$367,080→ 0 totalExercise: $51.52Exp: 2020-06-16→ Genzyme common stock (GENZ) (7,125 underlying)
Footnotes (2)
- [F1]The vested restricted stock units were scheduled to vest on the date of the 2011 annual meeting of shareholders.
- [F2]This option, which provided for vesting at the next annual meeting of shareholders, was cancelled upon the consummation of the sanofi-aventis tender offer in exchange for a payment representing (A) an amount of cash equal to the excess of $74.00 over the exercise price of the option, multiplied by the total number of shares subject to such options, and (B) one contingent value right (CVR) per cancelled option.